CTAS

TentativeAI MemoPost-earnings T+3

Cintas

As of 2026-09-28/Post-earnings T+3/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-09-28 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Report quality notice

peer set is too generic or lacks enough direct operating comparators

Action

—

Confidence

medium

Horizon

—

Key catalyst

Fiscal Q1 results and raised FY2027 guidance • 2026-09-23

Base target: $215 / p=55% prob

Biggest risk

The guidance raise was modest relative to expectations: post-print coverage put the new revenue midpoint slightly below consensus and adjusted EPS midpoint approximately in line. Oppenheimer retained Perform and said valuation largely reflects Cintas's favorable positioning. FTC review and eventual integration add uncertainty. Sources: https://ca.investing.com/news/earnings/cintas-beats-estimates-but-stock-edges-lower-4849893 and https://www.fidelity.com/news/article/company-news/202609251357MIDNIGHTUSEQUITY_A3715999

Invalidation

Break below $165 or thesis failure.

What would change my mind?

The quarter supports the positive thesis update: revenue and adjusted EPS exceeded reported consensus, organic growth reached 8.9%, and gross margin rose 120 basis points year over year. Truist raised its target to $230 from $225 while retaining Buy; Oppenheimer increased its FY2027 revenue estimate to $12.21 billion from $12.175 billion and adjusted EPS estimate to $5.50 from $5.43. [#SEC-8K-2026-09-23] Sources: https://www.investing.com/news/analyst-ratings/truist-raises-cintas-stock-price-target-to-230-on-strong-results-93CH-4914916 and https://www.fidelity.com/news/article/company-news/202609251357MIDNIGHTUSEQUITY_A3715999

Research note

Recommendation

—

Confidence

medium

As of

2026-09-28

Base target

$215

p=55%

Bull target

$235

p=30%

Bear target

$165

p=15%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

The quarter supports the positive thesis update: revenue and adjusted EPS exceeded reported consensus, organic growth reached 8.9%, and gross margin rose 120 basis points year over year.
Truist raised its target to $230 from $225 while retaining Buy; Oppenheimer increased its FY2027 revenue estimate to $12.21 billion from $12.175 billion and adjusted EPS estimate to $5.50 from $5.43.
[#SEC-8K-2026-09-23] Sources: https://www.investing.com/news/analyst-ratings/truist-raises-cintas-stock-price-target-to-230-on-strong-results-93CH-4914916 and https://www.fidelity.com/news/article/company-news/202609251357MIDNIGHTUSEQUITY_A3715999

BearKey bullets

A roughly 36.4-times guided adjusted EPS multiple leaves room for de-rating if organic growth or record margins soften.
[#SEC-8K-2026-09-23]
FTC review could delay or prevent the proposed UniFirst acquisition; management's expected closing window is not a regulatory decision.

WatchKey bullets

Fiscal Q1 results and raised FY2027 guidance

Summary

High-level snapshot

Recommendation

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Post-earnings T+3

Base case: $215 (p=55%)

Target spread vs base: +9% / -23%

Scenario probabilities

Bull Target: $235 (p=30%)Base Target: $215 (p=55%)Bear Target: $165 (p=15%)

Commentary

The T+3 evidence is constructive but mixed, supporting an upgrade from the March monitoring baseline without assuming a large near-term re-rating. Shares were reported down 1.2% premarket on September 23 despite the beat, while MT Newswires reported them up 1.3% on Friday afternoon; these are different snapshots, not a verified full-period return. Oppenheimer raised estimates but stayed at Perform, while Truist raised its target and kept Buy. The September 25 RankAlpha close anchor is $199.91. Sources: https://ca.investing.com/news/earnings/cintas-beats-estimates-but-stock-edges-lower-4849893, https://www.fidelity.com/news/article/company-news/202609251357MIDNIGHTUSEQUITY_A3715999 and https://www.investing.com/news/analyst-ratings/truist-raises-cintas-stock-price-target-to-230-on-strong-results-93CH-4914916

As of 2026-09-28 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

The quarter supports the positive thesis update: revenue and adjusted EPS exceeded reported consensus, organic growth reached 8.9%, and gross margin rose 120 basis points year over year.
Truist raised its target to $230 from $225 while retaining Buy; Oppenheimer increased its FY2027 revenue estimate to $12.21 billion from $12.175 billion and adjusted EPS estimate to $5.50 from $5.43.
[#SEC-8K-2026-09-23] Sources: https://www.investing.com/news/analyst-ratings/truist-raises-cintas-stock-price-target-to-230-on-strong-results-93CH-4914916 and https://www.fidelity.com/news/article/company-news/202609251357MIDNIGHTUSEQUITY_A3715999

Scenarios

Bull Target (Scenario probability)

$235 / p=30% prob

Base Target (Scenario probability)

$215 / p=55% prob

Bear Target (Scenario probability)

$165 / p=15% prob

Analysis 2026-09-28 · RankAlpha Sentiment Codex

Analysis reference price unavailable. Targets are shown without scenario returns.

Sentiment & Exposure

News Sentiment (30d)

0.35

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-09-23
Fiscal Q1 results and raised FY2027 guidance
Cintas reported $3.01 billion in revenue, 8.9% organic growth and 51.5% gross margin for the quarter ended August 31. It raised FY2027 revenue guidance to $12.15–$12.27 billion and adjusted EPS guidance to $5.45–$5.54. The results are public; the remaining question is whether post-print estimates and the share price sustain the initial positive interpretation. [#8-K-2026-09-23] [#SEC-8K-2026-09-23]
Prob 75.00% • Move 4.00% • Priced-in 75.00%
EVENT2026-12-31
FTC review of proposed UniFirst acquisition
Management said it remains engaged with the FTC and expects the proposed UniFirst transaction to close before the end of calendar 2026. Approval and closing are not assured, and FY2027 guidance excludes the transaction. The date reflects management's expected closing window, not a scheduled FTC decision. [#SEC-8K-2026-09-23]
Prob 65.00% • Move 8.00% • Priced-in 45.00%

Risks

A roughly 36.4-times guided adjusted EPS multiple leaves room for de-rating if organic growth or record margins soften. [#SEC-8K-2026-09-23]
FTC review could delay or prevent the proposed UniFirst acquisition; management's expected closing window is not a regulatory decision. [#SEC-8K-2026-09-23]
FY2027 guidance excludes UniFirst acquisition effects and adjusted EPS excludes non-recurring transaction expenses; GAAP costs and integration economics remain uncertain. [#SEC-8K-2026-09-23]
Quarterly tax-rate differences and $14.4 million of UniFirst transaction expenses complicate comparisons of reported EPS with adjusted EPS. [#SEC-8K-2026-09-23]

Peers

Symbol	Summary
UNF	Direct North American uniform and workwear-services comparator, also offering facility and first-aid products. Its pending acquisition by Cintas makes its trading valuation an unstable standalone benchmark; the transaction has not closed. Source: https://investors.unifirst.com/
VSTS	Direct North American operating comparator: Vestis provides uniform rental, laundering and workplace supplies, including mats, linens and restroom products. Its different scale limits valuation comparability. Source: https://ir.vestis.com/company-information

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-09-28

Loading AI feed…

Symbol

Summary

UNF

Direct North American uniform and workwear-services comparator, also offering facility and first-aid products. Its pending acquisition by Cintas makes its trading valuation an unstable standalone benchmark; the transaction has not closed. Source: https://investors.unifirst.com/

VSTS

Direct North American operating comparator: Vestis provides uniform rental, laundering and workplace supplies, including mats, linens and restroom products. Its different scale limits valuation comparability. Source: https://ir.vestis.com/company-information